United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Overall Market Size
2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2021 VS 2027
2.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top 23-Valent Pneumococcal Polysaccharide Vaccine Players in United States Market
3.2 Top United States 23-Valent Pneumococcal Polysaccharide Vaccine Companies Ranked by Revenue
3.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies
3.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies
3.5 United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 23-Valent Pneumococcal Polysaccharide Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Players in United States Market
3.8.1 List of Tier 1 23-Valent Pneumococcal Polysaccharide Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Markets, 2021 & 2027
4.1.2 Single Dose Vial
4.1.3 Pre-filled Syringe
4.2 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
4.2.1 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2021
4.2.2 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2022-2027
4.2.3 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
4.3.1 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2021
4.3.2 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2022-2027
4.3.3 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2021 & 2027
5.1.2 For Children (2-10)
5.1.3 For Person (10-64)
5.1.4 For The Old (Above or equal to 65)
5.2 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
5.2.1 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2021
5.2.2 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2022-2027
5.2.3 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
5.3.1 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2021
5.3.2 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2022-2027
5.3.3 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 MSD
6.1.1 MSD Corporation Information
6.1.2 MSD Overview
6.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Description
6.1.5 MSD Recent Developments
6.2 Sanofipasteur
6.2.1 Sanofipasteur Corporation Information
6.2.2 Sanofipasteur Overview
6.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Description
6.2.5 Sanofipasteur Recent Developments
6.3 CDIBP
6.3.1 CDIBP Corporation Information
6.3.2 CDIBP Overview
6.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Description
6.3.5 CDIBP Recent Developments
7 United States 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Analysis
7.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, 2016-2027
7.2 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 23-Valent Pneumococcal Polysaccharide Vaccine Supply Chain Analysis
9.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
9.2 23-Valent Pneumococcal Polysaccharide Vaccine Upstream Market
9.3 23-Valent Pneumococcal Polysaccharide Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of 23-Valent Pneumococcal Polysaccharide Vaccine in United States Market
Table 2. Top 23-Valent Pneumococcal Polysaccharide Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies, (K Dose), 2016-2021
Table 6. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Price (2016-2021) & (US$/Dose)
Table 8. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 9. List of Tier 1 23-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Single Dose Vial
Table 12. Major Manufacturers of Pre-filled Syringe
Table 13. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2016-2021
Table 17. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2022-2027
Table 18. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2016-2021
Table 22. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2022-2027
Table 23. MSD Corporation Information
Table 24. MSD Description and Major Businesses
Table 25. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 26. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 27. MSD Recent Developments
Table 28. Sanofipasteur Corporation Information
Table 29. Sanofipasteur Description and Major Businesses
Table 30. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 31. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 32. Sanofipasteur Recent Developments
Table 33. CDIBP Corporation Information
Table 34. CDIBP Description and Major Businesses
Table 35. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 36. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 37. CDIBP Recent Developments
Table 38. 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose) of Key Manufacturers in United States Market, 2019-2021 (K Dose)
Table 39. United States 23-Valent Pneumococcal Polysaccharide Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 40. 23-Valent Pneumococcal Polysaccharide Vaccine Market Opportunities & Trends in United States Market
Table 41. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers in United States Market
Table 42. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints in United States Market
Table 43. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials
Table 44. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials Suppliers in United States Market
Table 45. Typical 23-Valent Pneumococcal Polysaccharide Vaccine Downstream
Table 46. 23-Valent Pneumococcal Polysaccharide Vaccine Downstream Clients in United States Market
Table 47. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in United States Market
List of FiguresFigure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
Figure 3. 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
Figure 4. United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview: 2020
Figure 5. United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. 23-Valent Pneumococcal Polysaccharide Vaccine Sales in United States Market: 2016-2027 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2020
Figure 9. Single Dose Vial Product Picture
Figure 10. Pre-filled Syringe Product Picture
Figure 11. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 12. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 13. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose), 2016-2027
Figure 14. For Children (2-10)
Figure 15. For Person (10-64)
Figure 16. For The Old (Above or equal to 65)
Figure 17. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 18. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 19. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose), 2016-2027
Figure 20. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. United States 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), 2016-2027
Figure 24. 23-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
Figure 25. Marketing Channels